Galderma Group
Logotype for Galderma Group AG

Galderma Group (GALD) investor relations material

Galderma Group Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Galderma Group AG
Q4 2025 earnings summary5 Mar, 2026

Executive summary

  • Achieved record net sales of $5.207 billion in 2025, up 17.7% year-over-year at constant currency, surpassing $5 billion for the first time, driven by broad-based volume growth across all geographies and product categories.

  • Core EBITDA reached $1.211 billion (23.3% margin), up 18.9% year-over-year, with margin expansion and core EPS up 76.7% to $3.69, supported by strong operational leverage, reduced financing/tax expenses, and share repurchases.

  • Major product launches and innovation, including Nemluvio and Relfydess, fueled growth, with all top 10 markets growing and eight achieving double-digit growth.

  • Transformation to a global dermatology leader largely completed, with strengthened balance sheet and net leverage reduced to 1.5x.

  • Significant ESG progress, including AA MSCI ESG rating and improved non-financial indicators.

Financial highlights

  • Net sales: $5.207 billion, up 17.7% year-over-year at constant currency.

  • Core EBITDA: $1.211 billion (23.3% margin), up 18.9% year-over-year; margin expanded by 24 basis points.

  • Core net income: $871 million, up 75.4% year-over-year.

  • Core EPS: $3.69, up 76.7% year-over-year.

  • Cash generated from operations: $1.441 billion; early debt repayment of $240 million; $363 million in share repurchases.

Outlook and guidance

  • 2026 guidance: net sales growth of 17–20% at constant currency; Core EBITDA margin of approximately 26%.

  • Mid-term (2023–2027) guidance: Group net sales CAGR of 15–17% at constant currency; margin expansion of 450–550 basis points expected by 2027.

  • Nemluvio peak sales guidance raised to above $4 billion globally; expected to break even in 2026, one year ahead of plan.

  • Foreign exchange expected to positively impact net sales but negatively impact Core EBITDA margin.

Nemluvio's Q1 gross-to-net impact
Filler market softness: Galderma's mitigation
Operating leverage drivers for 2026 margin
Rationale for doubling Nemluvio peak sales target
Ipsen arbitration impact on distribution rights
Strategy for capturing GLP-1 patient demand
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next Galderma Group earnings date

Logotype for Galderma Group AG
Q1 2026 TU23 Apr, 2026
Galderma Group
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Galderma Group earnings date

Logotype for Galderma Group AG
Q1 2026 TU23 Apr, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Galderma Group AG, based in Zug, Switzerland, is a global dermatology company. It is committed exclusively to the field of dermatological care, encompassing a wide range of products and treatments across three main areas: Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology. Galderma's offerings include widely recognized brands and solutions aimed at enhancing skin health for consumers and patients, supported by robust research and development efforts. The company is headquartered in Zug, Switzerland, and its shares are listed on the SIX Swiss Exchange.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage